Nanotechnology Approaches for Enhanced CNS Drug Delivery in the Management of Schizophrenia

Rajalakshmi Rajendran ¹ , Krishnakumar Neelakandha Menon ² * , Sreeja Chandrasekharan Nair ¹ *

Cited by CrossRef: 7

1- Sondhi P, Lingden D, Bhattarai J, Demchenko A, Stine K. Applications of Nanoporous Gold in Therapy, Drug Delivery, and Diagnostics. Metals. 2022;13(1):78 [Crossref]

2- Rajendran R, Kunnil A, Radhakrishnan A, Thomas S, Nair S. Current Trends and Future Perspectives for Enhanced Drug Delivery to Central Nervous System in Treatment of Stroke. Ther Deliv. 2023;14(1):61 [Crossref]

3- Wani S, Singh S, Sharma N, Zahoor I, Grewal S, Gupta S. Transferosome-Based Intranasal Drug Delivery Systems for the Management of Schizophrenia: a Futuristic Approach. BioNanoSci. 2024;14(4):3811 [Crossref]

4- Kato H, Shiraishi C, Hagihara M, Mikamo H, Iwamoto T. Association between voriconazole-induced visual hallucination and dopamine in an analysis of the food and drug administration (FDA) adverse event reporting system database. Sci Rep. 2024;14(1) [Crossref]

5- Mathew A, Mohapatra S, Panonnummal R. Formulation and evaluation of magnesium sulphate nanoparticles for improved CNS penetrability. Naunyn-Schmiedeberg's Arch Pharmacol. 2023;396(3):567 [Crossref]